Investor mix
2 investors on record; lead investors include Doool Industrial, Shenzhen Hepalink Pharmaceutical.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |
Developing tumor antigen-specific monoclonal IgE antibodies for combinatorial immunotherapy
2 investors on record; lead investors include Doool Industrial, Shenzhen Hepalink Pharmaceutical.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |